In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merz Pharmaceuticals GmbH

https://www.merz.com/

Latest From Merz Pharmaceuticals GmbH

Deal Watch: Novartis Acquires Gene Therapy Candidate From AvroBio

AvroBio retains rights to its other HSC gene therapy candidates. Alimera Acquires Further Commercial Rights To Eyepoint’s Uveitis Drug.

Deal Watch Business Strategies

Japan's NEC Expands Biopharma Presence With AI-Based R&D

Japanese tech major re-structures its teams for artificial intelligence-based drug development and strategies while expanding its presence in Europe. With confidence in the utility of AI for discovery, it is retaining a key focus on oncology while adding infectious diseases to its targets.

Artificial Intelligence Innovation

iPLEDGE REMS: US FDA Advisory Cmte. Supports Relaxing Restrictions But Wants More Data

Panel favors elimination of 19-day lockout after patients who can become pregnant miss the first prescription pickup and continuation of at-home pregnancy tests. Members call for more data from isotretinoin sponsors on why acne patients are not participating in pregnancy registry and on disparities by race and ethnicity.

Advisory Committees Risk Management

iPLEDGE REMS: FDA Panel To Consider Changing Pregnancy Testing, Counseling Requirements

Advisory committee to discuss proposed changes to isotretinoin REMS to minimize burden and treatment delays while preventing risk of fetal exposure. Agency recommends against at-home pregnancy tests.

Advisory Committees Risk Management
See All

Company Information

  • Industry
  • Diversified
  • Other Names / Subsidiaries
    • BioteCon Therapeutics GmbH
    • Cabochon Aesthetics, Inc.
    • ON Light Sciences, Inc.
    • Ulthera, Inc.
    • Merz Pharmaceuticals GmbH
    • Merz Pharma France
    • Merz North America, Inc.
    • Merz Pharma (Schweiz) Ag
    • Merz Pharma GmbH
UsernamePublicRestriction

Register